Bioventus annual return on equity
2022
2023
2024
2025
Bioventus Return on Equity (ROE) Growth & History (BVS)
Bioventus's return on equity was 13.69% for fiscal 2025.
View full Bioventus company overviewBioventus annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 13.69% | +36.16 pp |
| 2024 | 2024-12-31 | −22.47% | +40.17 pp |
| 2023 | 2023-12-31 | −62.64% | −22.16 pp |
| 2022 | 2022-12-31 | −40.48% | — |
Bioventus quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-27 | 16.03% | +11.21 pp |
| Q1 2026 | 2026-03-28 | 1.67% | +3.45 pp |
| Q4 2025 | 2025-12-31 | 8.43% | +8.69 pp |
| Q3 2025 | 2025-09-27 | 1.93% | +5.37 pp |
| Q2 2025 | 2025-06-28 | 4.82% | +20.76 pp |
| Q1 2025 | 2025-03-29 | −1.78% | +1.05 pp |
| Q4 2024 | 2024-12-31 | −0.26% | +3.21 pp |
| Q3 2024 | 2024-09-28 | −3.45% | +0.60 pp |
| Q2 2024 | 2024-06-29 | −15.94% | −13.96 pp |
| Q1 2024 | 2024-03-30 | −2.84% | +51.33 pp |
| Q4 2023 | 2023-12-31 | −3.47% | +6.08 pp |
| Q3 2023 | 2023-09-30 | −4.05% | +23.31 pp |
| Q2 2023 | 2023-07-01 | −1.98% | −0.37 pp |
| Q1 2023 | 2023-04-01 | −54.17% | −51.69 pp |
| Q4 2022 | 2022-12-31 | −9.55% | −9.43 pp |
| Q3 2022 | 2022-10-01 | −27.36% | −26.63 pp |
| Q2 2022 | 2022-07-02 | −1.62% | +1.29 pp |
| Q1 2022 | 2022-04-02 | −2.48% | — |
| Q4 2021 | 2021-12-31 | −0.12% | — |
| Q3 2021 | 2021-10-02 | −0.73% | — |
| Q2 2021 | 2021-07-03 | −2.91% | — |
Bioventus return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Bioventus's return on equity increased from −40.48% to 13.69%, a change of +54.17 percentage points. The latest reported quarter, Q2 2026, shows 16.03%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus source filings ↗